News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sutro Biopharma Inc
(NQ:
STRO
)
4.770
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
933
Open
4.770
Bid (Size)
4.780 (10)
Ask (Size)
4.850 (19)
Prev. Close
4.770
Today's Range
4.770 - 4.770
52wk Range
2.005 - 5.880
Shares Outstanding
60,416,916
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
STRO stock results show that Sutro Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 20, 2024
Via
Benzinga
Performance
YTD
+4.38%
+4.38%
1 Month
+19.55%
+19.55%
3 Month
+5.07%
+5.07%
6 Month
+1.27%
+1.27%
1 Year
+3.02%
+3.02%
More News
Read More
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
Via
Benzinga
Expert Outlook: Sutro Biopharma Through The Eyes Of 10 Analysts
May 08, 2024
Via
Benzinga
What's Going On With Sutro Biopharma (STRO) Stock?
April 02, 2024
Via
Benzinga
STRO Stock Earnings: Sutro Biopharma Misses EPS, Beats Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 28, 2024
Via
Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
Via
Benzinga
Navigating 4 Analyst Ratings For Sutro Biopharma
March 27, 2024
Via
Benzinga
Expert Ratings for Sutro Biopharma
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 26, 2024
Via
Benzinga
STRO Stock Earnings: Sutro Biopharma Beats EPS, Beats Revenue for Q4 2023
March 25, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 30, 2023
Via
Benzinga
Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates
November 27, 2023
From
Vaxcyte, Inc.
Via
GlobeNewswire
Where Sutro Biopharma Stands With Analysts
October 23, 2023
Via
Benzinga
5 Analysts Have This to Say About Sutro Biopharma
October 06, 2023
Via
Benzinga
Where Sutro Biopharma Stands With Analysts
August 11, 2023
Via
Benzinga
6 Analysts Have This to Say About Sutro Biopharma
June 12, 2023
Via
Benzinga
Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
October 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
Sutro Biopharma Earnings Perspective: Return On Capital Employed
April 03, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
Via
Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
May 18, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
August 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close